编织型镍钛合金支架治疗桡头动静脉瘘吻合口附近狭窄
单中心回顾性研究纳入42例因吻合口附近狭窄导致桡头动静脉瘘功能不良的血透患者,置入Supera编织型镍钛合金支架。6个月和12个月的一期通畅率分别为92.5%和59.8%,辅助一期通畅率分别为97.5%和92.9%,再干预率0.31次/年,无瘘管丢失。
要点
- Supera支架治疗桡头AVF吻合口附近狭窄的12个月一期通畅率为59.8%。
- 辅助一期通畅率12个月达92.9%,再干预率低(0.31次/年)。
- 肱动脉流量术后显著增加,无AVF丢失或废弃。
核心结论
- 编织型Supera支架是治疗桡头动静脉瘘吻合口附近狭窄所致功能不良的有前景方法。
- 术后1年一期和辅助一期通畅率令人鼓舞,再干预率低,有助于长期维持AVF血管通路。
研究设计与样本
- 单中心回顾性研究,纳入42例连续患者(平均年龄66.7岁,范围40-84;26例男性)。
- 患者因吻合口附近狭窄导致AVF功能不良,于2014年2月至2018年2月期间接受Supera支架治疗。
- 三分之一患者既往接受过吻合口附近干预(球囊扩张或开放手术修正)。
主要发现
- 支架在所有患者中成功置入。
- 总体平均随访12.2±8.2个月(范围3.8-38.3)。
- 吻合口附近段6个月和12个月一期通畅率估计分别为92.5%和59.8%。
- 辅助一期通畅率6个月和12个月分别为97.5%和92.9%。
- 再干预(择期药物涂层球囊扩张)发生率为0.31次/年;1年随访期间2例AVF血栓形成,经球囊扩张血运重建。
临床怎么用
- 对于桡头AVF吻合口附近狭窄导致功能不良的血透患者,可考虑置入Supera编织型镍钛合金支架。
- 术后需监测一期通畅率,必要时行择期药物涂层球囊扩张再干预。
局限性
- 单中心回顾性研究,样本量42例,随访时间有限(平均12.2个月)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine the clinical outcomes in hemodialysis patients after implantation of a Supera stent to treat juxta-anastomotic stenosis in radiocephalic arteriovenous fistulas (AVF). MATERIALS AND METHODS: A single-center retrospective study was conducted of 42 consecutive patients (mean age 66.7 years, range 40-84; 26 men) who had a failing AVF due to juxta-anastomotic stenosis treated with the interwoven Supera stent between February 2014 and February 2018. A third of the patients had previous juxta-anastomotic intervention (either balloon angioplasty or open surgical revision). RESULTS: The stent was inserted successfully in all patients. Overall mean follow-up was 12.2±8.2 months (range 3.8-38.3). Juxta-anastomotic segment primary patency estimates at 6 and 12 months were 92.5% and 59.8%, respectively, with assisted primary patency rates of 97.5% and 92.9%. Reintervention (elective drug-coated balloon angioplasty) occurred at a rate of 0.31 procedures/year. Two AVFs thrombosed during the 1-year follow-up and were revascularized using balloon angioplasty. Ultrasound measurements of brachial artery flow rates increased significantly from 543.5±96.72 mL/min (range 430-644) before intervention to 919.2±355.9 mL/min (range 200-1600) after intervention (p=0.047). Arterial pressures on hemodialysis improved from -142.3±24.9 mm Hg (range -100 to -180) to -123.4±21.9 mm Hg (range -100 to -184; p=0.051). No AVFs were lost or abandoned during the follow-up period. CONCLUSION: The interwoven Supera stent is a promising treatment for failing AVFs with juxta-anastomotic stenosis. Encouraging 1-year primary and assisted primary patency was demonstrated, with a low reintervention rate. This treatment facilitates long-term maintenance of AVF vascular accesses.
引用
- Thomas SD, Peden S, Crowe P, et al. Interwoven Nitinol Stents to Treat Radiocephalic Anastomotic Arteriovenous Fistula Stenosis. J Endovasc Ther. 2019. PMID: 30973045. doi:10.1177/1526602819842851
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。